Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CAMEO CARTER MD, A PROFESSIONAL CORPORATION

NPI: 1447404611 · REDLANDS, CA 92373 · Pediatrics Physician · NPI assigned 11/13/2008

$1.83M
Total Medicaid Paid
70,094
Total Claims
65,674
Beneficiaries
68
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialCARTER, CAMEO (CEO AND MEDICAL DIRECTOR)
NPI Enumeration Date11/13/2008

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 11,741 $400K
2019 11,543 $399K
2020 12,786 $296K
2021 10,464 $220K
2022 8,707 $216K
2023 7,579 $148K
2024 7,274 $149K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 14,258 12,418 $681K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8,817 8,078 $252K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,226 3,861 $193K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3,576 3,440 $157K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1,583 1,167 $120K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,652 1,481 $87K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 4,806 4,660 $86K
92551 6,708 6,647 $68K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1,521 1,434 $64K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 846 839 $20K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 48 47 $18K
99215 Prolong outpt/office vis 206 188 $13K
96127 2,307 2,246 $12K
99173 3,298 3,290 $7K
83655 498 488 $7K
90686 949 946 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 331 300 $4K
99000 1,004 946 $4K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 48 48 $3K
99383 48 48 $3K
99381 56 56 $3K
87634 40 40 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 214 209 $2K
90651 326 326 $2K
85018 566 558 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 28 27 $1K
90670 293 292 $1K
0071A 22 22 $870.00
0072A 22 22 $870.00
90697 64 64 $824.93
81001 236 227 $785.62
99382 12 12 $727.92
90672 26 26 $579.95
0002A 25 15 $560.00
90633 210 207 $456.19
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 14 12 $432.32
90656 44 44 $396.00
90715 92 92 $309.69
90710 62 62 $258.46
90619 29 29 $258.39
90680 38 38 $231.86
G9920 Screening performed and negative 3,953 3,913 $213.60
90696 55 55 $142.60
99188 16 16 $92.68
90744 72 72 $80.63
90734 97 97 $44.57
90698 74 74 $9.28
90700 17 17 $9.08
G8510 Screening for depression is documented as negative, a follow-up plan is not required 611 610 $5.40
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 27 25 $3.57
G8511 Screening for depression documented as positive, follow-up plan not documented, reason not given 93 93 $0.00
99401 234 234 $0.00
99072 2,272 2,116 $0.00
G9919 Screening performed and positive and provision of recommendations 27 27 $0.00
G0444 Annual depression screening, 5 to 15 minutes 456 454 $0.00
99051 115 109 $0.00
99408 65 65 $0.00
90707 13 13 $0.00
96160 14 14 $0.00
99174 301 299 $0.00
96161 1,400 1,399 $0.00
36416 29 29 $0.00
1220F 236 234 $0.00
H0049 Alcohol and/or drug screening 542 537 $0.00
3351F 148 146 $0.00
S8110 Peak expiratory flow rate (physician services) 50 47 $0.00
99441 15 14 $0.00
90716 13 13 $0.00